Publication:
Cloning, expression and characterization of recombinant CagA protein of Helicobacter pylori using monoclonal antibodies: its potential in diagnostics

dc.contributor.coauthorSalih, Barik A.
dc.contributor.coauthorKarakus, Cebrail
dc.contributor.coauthorUlupinar, Zeynep
dc.contributor.coauthorAkbas, Fahri
dc.contributor.coauthorUslu, Merve
dc.contributor.coauthorBolek, Bora Kazim
dc.contributor.coauthorBayyurt, Nizamettin
dc.contributor.coauthorTurkay, Cansel
dc.contributor.kuauthorYazıcı, Duygu
dc.contributor.kuprofilePhD Student
dc.contributor.researchcenterKoç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
dc.contributor.schoolcollegeinstituteGraduate School of Health Sciences
dc.contributor.yokidN/A
dc.date.accessioned2024-11-10T00:06:21Z
dc.date.issued2020
dc.description.abstractHelicobacter pylori CagA protein plays an important role in the severity of the gastric diseases. Our aims were to clone the cagA 5'conserved region of the gene, characterize the recombinant CagA (rCagA) protein by monoclonal antibodies (mAbs) and to use this protein for the detection of anti-CagA antibodies by an ELISA test. Our developed rCagA protein (67 kDa) showed an amino acid sequence homology of 83% and 80% with Western and East Asian type strains respectively. Two anti-rCagA (BS-53, CK-02) mAbs and 2 additional rCagA proteins of smaller sizes (60 kDa, 28 kDa) were developed for epitope determination. The BS-53 mAb recognized all 3 rCagA proteins while CK-02 mAb recognized only 2 of them indicating recognition of different epitopes. An in-house indirect ELISA using rCagA was developed to detect anti-CagA antibodies in sera of 59 patients. The ELISA results obtained when compared to those of the PCR gave a sensitivity, specificity and accuracy of 81%, 100% and 88% respectively. We have developed for the first time: a rCagA protein that showed high sequence homology with both Western and East Asian type strains and an indirect ELISA of high performance which can be used to detect anti-CagA antibodies in sera of infected patients worldwide.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [111T370] This study was supported by the grant of the Scientific and Technological Research Council of Turkey (TUBITAK) (No: 111T370). The authors would like to thank Dr. Fatima Yucel, Dr. Esin Akcael, Dr. Hivda Polat and Harun Kocaaga for their technical assistance.
dc.description.volume68
dc.identifier.doi10.1016/j.biologicals.2020.09.002
dc.identifier.eissn1095-8320
dc.identifier.issn1045-1056
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-85090953397
dc.identifier.urihttp://dx.doi.org/10.1016/j.biologicals.2020.09.002
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16578
dc.identifier.wos594534700005
dc.keywordsHelicobacter pylori
dc.keywordsRecombinant CagA
dc.keywordsMonoclonal antibody
dc.keywordsELISA
dc.languageEnglish
dc.publisherElsevier
dc.sourceBiologicals
dc.subjectBiochemical engineering
dc.subjectBiotechnology
dc.subjectMicrobiology
dc.subjectPharmacology
dc.subjectPharmacy
dc.titleCloning, expression and characterization of recombinant CagA protein of Helicobacter pylori using monoclonal antibodies: its potential in diagnostics
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0001-9094-6542
local.contributor.kuauthorYazıcı, Duygu

Files